Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue 4, 2005, Pages 462-465

  Wojas Pelc, A ^a   Blaszczyk M ^a   Glinska M ^a   Jablonska S ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Facies leonina; High dose intravenous immunoglobulin; Lymphoma like lesions; Scleromyxedema

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN; MELPHALAN; PARAPROTEIN;

ADULT; ARTICLE; CASE REPORT; DRUG MEGADOSE; FACE DISORDER; FEMALE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; LYMPHOMA; MEDICAL DECISION MAKING; PARAPROTEINEMIA; PRIORITY JOURNAL; SCLEROMYXEDEMA; SYMPTOM; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR REGRESSION;

DIAGNOSIS, DIFFERENTIAL; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MIDDLE AGED; MYXEDEMA;

EID: 21744447373     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01134.x     Document Type: Article

References (23)

1. Gottron HA. Skleromyxedem (eine eigenartige Erscheinungsform von Myxothesaurodermie). Arch Dermatol 1954; 199: 71-91.
2. Montgomery H, Underwood LJ. Lichen myxedematosus (differentiation from cutaneous myxedemas or mucoid states). J Invest Dermatol 1953; 20: 213-236.
3. Sawada Y, Seishima M, Funabashi M et al. Papular mucinosis associated with scleroderma. Eur J Dermatol 1998; 8: 497-500.
4. Jabło-acnska S, Błaszczyk M. Scleromyxedema is a scleroderma-like disorder and not a coexistence of scleroderma with papular mucinosis. Eur J Dermatol 1999; 9: 551-554.
5. Beta-Csorgo Z, Husz S, Foldes M et al. Scleromyxedema. J Am Acad Dermatol 1999; 40: 343-346.
6. Loggini B, Pingitore R, Avvenente A, Giuliano G, Barachini P. Lichen myxedematosus with systemic involvement: clinical and autopsy findings. J Am Acad Dermatol 2001; 45: 606-608.
7. Goodby A, Bergstresser PR, Chaker B, Pandya AG. Fatal scleromyxedema: report of a case and review of the literature. J Am Acad Dermatol 1998; 38: 289-294.
8. Kantor GR, Bergfeld WE, Katzin WE et al. Scleromyxedema associated with scleroderma renal disease and acute psychosis. J Am Acad Dermatol 1986; 14: 879-888.
9. Gonzalez J, Palangio M, Schwartz J, Klainer AS, Bisaccia E. Scleromyxedema with dermato-neuro syndrome. J Am Acad Dermatol 2000; 42: 927-928.
10. Wright RC, Franco RS, Denton D, Blaney DJ. Scleromyxedema. Arch Dermatol 1976; 112: 63-66.
11. Rongioletti F, Rebora A. Update classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-281.
12. Westheim AI, Lookingbill DP. Plasmapheresis in a patient with scleromyxedema. Arch Dermatol 1987; 123: 786-789.
13. Depaire-Duclos F, Renuy F, Dandurand M, Guillot B. Papular mucinosis with rapid spontaneous regression in an HIV-infected patient. Eur J Dermatol 1998; 8: 353-354.
14. Boffa MJ, Ead RD. Spontaneous improvement of scleromyxedema. Clin Exp Dermatol 1995; 20: 157-160.
15. Righi A, Schiavon F, Jabłońska S et al. Intravenous immunoglobulins control scleromyxedema. Ann Rheum Dis 2002; 61: 59-61.
16. Webster GF, Matsuoka LY, Burchmore D. The association of potentially lethal neurological syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 1993; 28: 105-108.
17. Dahl MV, Bridges AG. Intravenous immune globulin: Fighting antibodies with antibodies. J Am Acad Dermatol 2001; 45: 775-783.
18. Rütter A, Luger ThA. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. J Am Acad Dermatol 2001; 44: 1010-1024.
19. Leung DY. Immunoregulatory effects of IVIg in Kawasaki disease and other autoimmune diseases. Clin Rev Allergy 1992; 10: 93-104.
20. Dirschka T, Kastner U, Behrens S, Altmeyer P. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol 1998; 39: 789-790.
21. Lister RK, Jolles S, Whittaker S et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). J Am Acad Dermatol 2000; 43: 403-408.
22. Tschen JA, Chang JR. Scleromyxedema: treatment with interferon alfa. J Am Acad Dermatol 1999; 40: 303-307.
23. D'Incan M, Franck F, Kanold J et al. Mucinose papuloscléreuse (scleromyxoedeme) cutanéo-systémique. Remission apres photochimiothérapie extracorporelle et bolus de corticoides. Ann Dermatol Venereol 2001; 128: 38-41.